In 1991 a group of pharmaceutical managers sets up PH&T to develop and distribute generic drugs in niche therapeutic areas through local partners both in Italy and abroad. In the following years the Company shareholders structure changes and the strategy is broadened, adding the development of a portfolio of injectable products for hospital use

In 1999 PH&T expands its activities in markets outside Europe and sets up an hospital line in Italy with the specific aim of establishing a direct presence in the market. Six years later, in 2005, PH&T sells off the flourishing hospital business in order to concentrate on product development and enlarge its presence in international markets.

The active internationalization strategy, begun in 2002, allowed PH&T to rapidly expand its marketing presence and to create new outsourcing opportunities.

	Agreements At the end of the 2008 financial year, over 160 agreements had been signed with licensees and distributors operating in 75 countries. Most of the sales are still represented by top EU countries, with revenues from asian markets growing rapidly.
	Manufacturing PH&T’s products are contract manufactured in different production sites across Europe. The outsourcing strategy allows PH&T to choose for each of its products the manufacturer with most experience in the specific pharmaceutical form and production scale